{"format":1,"id":"118-hr-467","congress":118,"number":"H.R. 467","kind":"bill","group":"bills","title":"HALT Fentanyl Act","title_source":"Short Title(s) as Passed House","official_title":"To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.","titles":[{"type":"Official Title as Introduced","title":"To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes."},{"type":"Display Title","title":"HALT Fentanyl Act"},{"type":"Short Titles from RFS (Referred to Senate) bill text","title":"HALT Fentanyl Act"},{"type":"Short Titles from RFS (Referred to Senate) bill text","title":"Halt All Lethal Trafficking of Fentanyl Act"},{"type":"Short Title(s) as Introduced","title":"Halt All Lethal Trafficking of Fentanyl Act"},{"type":"Short Title(s) as Introduced","title":"HALT Fentanyl Act"},{"type":"Short Title(s) as Reported to House","title":"HALT Fentanyl Act"},{"type":"Short Title(s) as Reported to House","title":"Halt All Lethal Trafficking of Fentanyl Act"},{"type":"Short Title(s) as Passed House","title":"HALT Fentanyl Act"},{"type":"Short Title(s) as Passed House","title":"Halt All Lethal Trafficking of Fentanyl Act"}],"outcome":"passed_house","law_number":null,"introduced":"2023-01-24","chambers":{"house":{"status":"roll_call","date":"2023-05-25","vote":{"id":"118-2023-h237","question":"On Passage","title":"HALT Fentanyl Act","result":"Passed","yea":289,"nay":133,"present":0,"not_voting":13,"source":"https://clerk.house.gov/evs/2023/roll237.xml"}},"senate":{"status":"na","date":null,"vote":null}},"president":{"status":"na","date":null},"vice_president_tie_breaker":null,"latest_action":{"text":"Received in the Senate and Read twice and referred to the Committee on the Judiciary.","date":"2023-05-30"},"nominees":null,"amendments":[{"number":"H.Amdt. 184","sponsor":"Rep. Pettersen, Brittany [D-CO-7]","purpose":"Amendment sought to prevent H. R. 467 from taking effect until the Secretary of Health and Human Services and the Attorney General each certify that H. R. 467 will lead to a reduction in overdose deaths.","result":"Failed","date":"2023-05-25","yea":190,"nay":233,"present":0,"not_voting":18,"source":"https://clerk.house.gov/evs/2023/roll236.xml"}],"other_votes":[{"chamber":"house","date":"2023-05-25","question":"On Agreeing to the Amendment","title":"","result":"Failed","yea":190,"nay":233,"present":0,"not_voting":18,"kind":"amendment","source":"https://clerk.house.gov/evs/2023/roll236.xml"}],"crs_summary":{"date":"2023-05-25","stage":"Passed House","blocks":[{"k":"h","t":"Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act"},{"k":"p","t":"This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act."},{"k":"p","t":"(The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.)"},{"k":"p","t":"Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term)."},{"k":"p","t":"Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration."},{"k":"p","t":"The bill also makes several other changes to registration requirements for conducting research with controlled substances, including"},{"k":"li","t":"permitting a single registration for related research sites in certain circumstances,","d":1},{"k":"li","t":"waiving the requirement for a new inspection in certain situations, and","d":1},{"k":"li","t":"allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.","d":1},{"k":"p","t":"Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance."}],"words":314},"summary":{"main_subject":{"text":"Adds fentanyl-related substances as a class to schedule I of the Controlled Substances Act, applies fentanyl analogue penalties to them, and changes registration requirements for research with controlled substances.","cites":[{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#H7FB25967C72D4C36B30CB40B20BB8722"},{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#HE11DA0432FDC4808B7B2B29B5C14B6A3"},{"label":"Sec. 5","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#HE1EBA402EFDF40A3A765F6C413484BF3"}]},"core_areas":["Class scheduling of fentanyl-related substances in schedule I","Penalties for offenses involving fentanyl-related substances","Registration requirements for research with schedule I controlled substances","Rulemaking by the Attorney General"],"what_it_does":[{"text":"Adds to schedule I of the Controlled Substances Act any material, compound, mixture, or preparation containing a fentanyl-related substance, defined as a substance structurally related to fentanyl by one or more listed modifications.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#H7FB25967C72D4C36B30CB40B20BB8722"}},{"text":"Excludes from that class a substance controlled by action of the Attorney General under section 201 or expressly listed in another schedule.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#H7FB25967C72D4C36B30CB40B20BB8722"}},{"text":"Adds the words \"or a fentanyl-related substance\" after \"any analogue\" of the named fentanyl compound in the penalty provisions of section 401(b)(1) of the Controlled Substances Act and section 1010(b) of the Controlled Substances Import and Export Act.","cite":{"label":"Sec. 5","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#HE1EBA402EFDF40A3A765F6C413484BF3"}},{"text":"Lets a practitioner conduct certain schedule I research 30 days after sending the Attorney General a notice, if the practitioner already holds a schedule I or II research registration.","cite":{"label":"Sec. 3","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#HE11DA0432FDC4808B7B2B29B5C14B6A3"}},{"text":"Requires the Attorney General to issue rules to implement the Act not later than 6 months after enactment, and allows them to be issued as interim final rules.","cite":{"label":"Sec. 4","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#H5A6E21F9665E4616A43845E0F99B872C"}},{"text":"States that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, 346 F. Supp. 3d 363 (2018).","cite":{"label":"Sec. 6","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#H7CEE557633334891979E5C7AB02D993B"}}],"unexpected":[{"category":"off_subject","items":[{"cite":{"label":"Sec. 6","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh#H7CEE557633334891979E5C7AB02D993B"},"heading":"Applicability; other matters","effect":"Adds a sense of Congress statement agreeing with the interpretation of the Controlled Substances Act in a named 2018 federal district court decision, and includes a rule of construction for conduct before enactment.","amount":null,"quote":"The Congress agrees with the interpretation of the Controlled Substances Act (21 U.S.C. 801 et seq.) in United States v. McCray, 346 F. Supp. 3d 363 (2018)."}]}],"version":{"type":"Engrossed in House","date":"2023-05-25","rule":"passed","href":"https://www.congress.gov/bill/118th-congress/house-bill/467/text/eh"},"current":true,"model":"claude-sonnet-5-5","approved":"2026-10-02","approved_by":"checks"},"sources":{"congress_gov":"https://www.congress.gov/bill/118th-congress/house-bill/467","text":"https://www.congress.gov/bill/118th-congress/house-bill/467/text"},"card":{"image":"card/item/118-hr-467.png","v":"b57b1f47e05c","alt":"Votes on Record. H.R. 467, 118th Congress: HALT Fentanyl Act. House: 289 Yea, 133 Nay. Outcome: Passed House, 25 May 2023."}}